SEC Comment Letter 0000000000-24-012961 to Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070) (NEUP)
Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070)
Date: Nov. 21, 2024 · CIK: 0001191070 · Accession: 0000000000-24-012961
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283306
Letter
November 21, 2024 Spyros Papapetropoulos President, Chief Executive Officer and Director Bionomics Limited 200 Greenhill Road Eastwood SA 5063 Australia Re:Bionomics Limited Registration Statement on Form S-3 Filed November 18, 2024 File No. 333-283306 Dear Spyros Papapetropoulos: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Theodore Ghorra, Esq.
Show Raw Text
November 21, 2024
Spyros Papapetropoulos
President, Chief Executive Officer and Director
Bionomics Limited
200 Greenhill Road
Eastwood SA 5063
Australia
Re:Bionomics Limited
Registration Statement on Form S-3
Filed November 18, 2024
File No. 333-283306
Dear Spyros Papapetropoulos:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Theodore Ghorra, Esq.